Suppr超能文献

骨髓辅助性 T 细胞具有 Th1 表型,可诱导前体 B 急性淋巴细胞白血病患者白血病细胞的激活和增殖。

Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.

机构信息

Experimental Infectious Diseases and Cancer Research, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.

Division of Otolaryngology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.

出版信息

Oncogene. 2019 Mar;38(13):2420-2431. doi: 10.1038/s41388-018-0594-4. Epub 2018 Dec 7.

Abstract

Precursor B cell acute lymphoblastic leukemia (BCP-ALL) constitutes the leading cause of cancer-related death in children. While chromosomal alterations contribute to BCP-ALL pathogenesis, they are insufficient for leukemia development. Epidemiological data and evidence from a mouse model suggest that immune responses to infections may trigger the emergence of leukemia, but the mechanisms remain unclear. Here, we show that T helper (Th) cells from bone marrow of pediatric BCP-ALL patients can be attracted and activated by autologous BCP-ALL cells. Bone-marrow Th cells supportively interacted with BCP-ALL cells, inducing upregulation of important surface molecules and BCP-ALL cell proliferation. These Th cells displayed a Th1-like phenotype and produced high levels of IFN-γ. IFN-γ was responsible for the upregulation of CD38 in BCP-ALL cells, a molecule which we found to be associated with early relapse, and accountable for the production of IP-10, a chemokine involved in BCP-ALL migration and drug resistance. Thus, our data provide mechanistic support for an involvement of Th cell immune responses in the propagation of BCP-ALL and suggest that BCP-ALL cell-supportive Th cells may serve as therapeutic target.

摘要

前 B 细胞急性淋巴细胞白血病(BCP-ALL)是导致儿童癌症相关死亡的主要原因。虽然染色体改变有助于 BCP-ALL 的发病机制,但它们不足以导致白血病的发生。流行病学数据和小鼠模型的证据表明,感染的免疫反应可能引发白血病的发生,但具体机制尚不清楚。在这里,我们表明来自儿科 BCP-ALL 患者骨髓的辅助性 T 细胞(Th 细胞)可被自身 BCP-ALL 细胞吸引和激活。骨髓 Th 细胞与 BCP-ALL 细胞支持性相互作用,诱导重要表面分子的上调和 BCP-ALL 细胞的增殖。这些 Th 细胞表现出 Th1 样表型,并产生高水平的 IFN-γ。IFN-γ 负责上调 BCP-ALL 细胞表面的 CD38,我们发现该分子与早期复发相关,并负责产生 IP-10,一种参与 BCP-ALL 迁移和耐药性的趋化因子。因此,我们的数据为 Th 细胞免疫反应参与 BCP-ALL 的传播提供了机制支持,并表明 BCP-ALL 细胞支持性 Th 细胞可能成为治疗靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验